UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060422
Receipt number R000069120
Scientific Title Study on the effects of the combination of food ingredients and exercise on frailty
Date of disclosure of the study information 2026/01/22
Last modified on 2026/01/21 13:45:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on the effects of the combination of food ingredients and exercise on frailty

Acronym

Study on the effects of the combination of food ingredients and exercise on frailty

Scientific Title

Study on the effects of the combination of food ingredients and exercise on frailty

Scientific Title:Acronym

Study on the effects of the combination of food ingredients and exercise on frailty

Region

Japan


Condition

Condition

To verify the effects of food ingredients on frailty.

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the effects of food ingredients on frailty.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

muscle mass, muscle strength

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Participants consumed test food for two months

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Participants who has the ability to walk

Key exclusion criteria

Participants who is currently receiving any medications or outpatient treatment.
Participants who is currently doing exercise or diet under the supervision of a doctor
Participants who is may develop allergy due to the test food

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yoshitake
Middle name
Last name Baba

Organization

ITO EN, LTD.

Division name

Central Research Institute

Zip code

421-0516

Address

21 Mekami, Makinohara, Shizuoka, Japan

TEL

0548-54-1247

Email

yoshi-baba@itoen.co.jp


Public contact

Name of contact person

1st name Yoshitake
Middle name
Last name Baba

Organization

ITO EN, LTD.

Division name

Central Research Institute

Zip code

421-0516

Address

21 Mekami, Makinohara, Shizuoka, Japan

TEL

0548-54-1247

Homepage URL


Email

yoshi-baba@itoen.co.jp


Sponsor or person

Institute

ITO EN, LTD.

Institute

Department

Personal name



Funding Source

Organization

ITO EN, LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

ITO EN, LTD.

Address

21 Mekami, Makinohara, Shizuoka, Japan

Tel

0548-54-1247

Email

-


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 01 Month 16 Day

Date of IRB


Anticipated trial start date

2026 Year 01 Month 23 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 01 Month 21 Day

Last modified on

2026 Year 01 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069120